Roche launches cobas® MRI for tau and amyloid biomarkers for diagnosing Alzheimer's disease new test allows for non-invasive detection of Alzheimer's pathology through cerebrospinal fluid analysis, potentially enabling earlier diagnosis and treatment interventions.
Quanterix Corporation receives FDA approval for Simoa P-tau217 assay for Alzheimer's disease diagnosis highly sensitive blood test offers a less invasive option for detecting
Alzheimer's pathology, further democratizing and simplifying diagnosis.
Bio-Techne Corporation acquires Akoya Biosciences for USD 850 million, strengthening its digital pathology portfolio strategic move aims to create a comprehensive platform for analyzing and interpreting tissue samples using AI and machine learning, driving precision in neuropathology
List of Neuropathology Key Companies in the Market
Neuropathology Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)